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E-mail address: isegura@inf.uc3m.es (I. Segura-BedImportant progress in treating diseases has been possible thanks to the identiﬁcation of drug targets.
Drug targets are the molecular structures whose abnormal activity, associated to a disease, can be mod-
iﬁed by drugs, improving the health of patients. Pharmaceutical industry needs to give priority to their
identiﬁcation and validation in order to reduce the long and costly drug development times. In the last
two decades, our knowledge about drugs, their mechanisms of action and drug targets has rapidly
increased. Nevertheless, most of this knowledge is hidden in millions of medical articles and textbooks.
Extracting knowledge from this large amount of unstructured information is a laborious job, even for
human experts. Drug target articles identiﬁcation, a crucial ﬁrst step toward the automatic extraction
of information from texts, constitutes the aim of this paper. A comparison of several machine learning
techniques has been performed in order to obtain a satisfactory classiﬁer for detecting drug target articles
using semantic information from biomedical resources such as the Uniﬁed Medical Language System. The
best result has been achieved by a Fuzzy Lattice Reasoning classiﬁer, which reaches 98% of ROC area
measure.
 2010 Elsevier Inc. All rights reserved.1. Introduction
A drug target is deﬁned as a molecular structure within the
organism, that is linked to a disease, and whose activity is either
stimulated or inhibited by drugs that are administered to ﬁght or
diagnose the said disease [1]. Several studies have tried to estimate
the total number of drug targets [1,2], however, no consensus has
been reached yet. While some studies [1] estimate that current tar-
get counts are of the order of 100, other suggest a higher order of
magnitude ([3] reported 14,000 targets).
In recent years, important progress in treating diseases such as
cancer, AIDS, or Parkinson’s disease, among many others, has been
possible thanks to the identiﬁcation of drug targets linked to these
diseases [4–6]. The current drug discovery process is mainly fo-
cused on the search and validation of drug candidates that act on
a particular therapeutic target [7]. Firstly, the process of a particu-
lar disease is studied and its physiologic mechanisms are deter-
mined to detect the drug targets related to this disease. Then,
new drugs are designed to act on these targets. Due to the high cost
and the long time required by the drug development process, phar-
maceutical industry needs to improve the strategies for prioritizing
targets and drug candidates in the drug discovery process. A broad-
er knowledge of these targets can help to understand the mecha-ll rights reserved.
mar).nisms of action of drugs at molecular level and provide insights
that guide drug design and the search for new targets.
As a consequence of the above, new research studies on drug
targets are continually published [8–10]. In addition, during the
last years there has been a growing interest in the development
of useful knowledge resources about drug targets. The Therapeutic
Target Database (TTD) [11] was developed to provide public and
accessible information about 1535 protein and nucleic acid targets
reported in the literature, their targeted disease conditions, and the
drugs that act on each of these targets. Recently, the Drug Target
Prioritization Network, established by the World Health Organiza-
tion (WHO), has developed the Drug Target Tropical Disease Re-
search (TDR1) Prioritization Database [12], a new online resource
to integrate genomic information relevant for drug discovery on
pathogens that cause human infectious diseases. The aforemen-
tioned resources can facilitate researchers in looking for information
on possible targets, and consequently, they can have an important
impact on the opening of new ways for drug discovery. However,
the main problem of these resources is that their manual construc-
tion is a time-consuming, labor-intensive and expensive task.
Despite the availability of a growing amount of structured phar-
macological, biological, genetic and medical information, most of
this information is unstructured, hidden in millions of medical
articles and textbooks, and accessible only to human specialists.
Furthermore, knowledge on drug targets is far from being com-1 http://TDRtargets.org.
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still unknown on the human metabolism [1].
Manual management and analysis of the large amount of tex-
tual information in this ﬁeld is an infeasible task. The overwhelm-
ing number of publications makes it impossible to keep up-to-date
with the recent and relevant developments in the biomedical do-
mains. Extracting knowledge from this large amount of unstruc-
tured information is a laborious job, even for human experts.
Therefore, a challenging goal for improving the efﬁciency of the
drug discovery process is to develop automated systems that aid
researchers managing this large amount of publications.
To our knowledge, only one approach has addressed the semi-
automatic data-base curation of drug–target interactions. In the
SuperTarget2 [13] database, the efforts for drug target annotation
were reduced by the use of the text mining tool EbiMed [14]. This
tool retrieves abstracts by querying keywords from MedLine and ﬁl-
ters sentences that contain at least two biomedical entities. EBIMed
labels a protein name if it co-occurs with another protein, gene, drug
or species name. In order to recognize these biomedical terms, Ebi-
Med uses a set of bioinformatics resources: UniProtKB/Swiss-Prot
[15], MedLinePlus web site3, Gene Ontology [16] and the NCBI tax-
onomy4. Subsequently, the list of real relations was assembled by
manual curation.
Machine learning techniques are currently used for classiﬁca-
tion tasks, and in this work we apply them for detecting articles
that contain drug–target interactions, in order to reduce the time
and effort needed to manually curate a drug–target database. In
this paper, a variety of machine learning techniques have been ap-
plied to the classiﬁcation of drug target relevant articles in order to
obtain a satisfactory classiﬁer. The approach is evaluated in the
context of a binary classiﬁcation of documents. This binary classi-
ﬁcation can correspond to a stage in the information retrieval pro-
cess where the possible relevant documents are selected from the
mass of non-relevant ones before being more thoroughly examined
later on.
In addition, we believe that UMLS Metathesaurus [17], a com-
prehensive ontology that integrates a wealth of biomedical termi-
nological resources, may be more comprehensive and robust than
the resources used by EbiMed. We hypothesize that the semantic
information obtained from biomedical resources such as UMLS or
MeSH (Medical Subject Headings) [18] index can beneﬁt the clas-
siﬁcation of documents because of the possibility of reducing the
sparseness of data.
The paper is organized as follows: Section 2 reviews the related
works. Section 3 describes our proposal. Section 4 presents the
evaluation framework of our approach and the results we have ob-
tained. Section 5 presents conclusions and future works.2. Related work
The task we are facing requires knowledge about available bio-
medical information resources, suitable solutions for biomedical
text mining problems, and biomedical text classiﬁcation tools.
These three themes are the subjects of the following subsections.2.1. Biomedical information resources
Life science disciplines are proliﬁc producers of massive
amounts of information distributed in a huge number of biblio-
graphical and terminological knowledge resources. Although a
comprehensive review of these resources is out of the scope of this2 http://insilico.charite.de/supertarget/.
3 http://medlineplus.gov/.
4 http://www.ncbi.nlm.nih.gov/Taxonomy/.paper, this section provides an outline of the main resources used
by our proposal.
MedLine is a bibliographic database covering several biological
and bio-medical ﬁelds with about 18 million references of journal
articles. PubMed5 is an online service that provides public access to
Medline. MeSH is a hierarchy of medical terms that is used to index
articles included in MedLine. Each Medline article is manually asso-
ciated to a set of MeSH concepts which characterizes it. Thus, MeSH
provides a consistent way to deal with the terminological variability
problem which may adversely affect the retrieval information pro-
cess. MeSH is part of the Uniﬁed Medical Language Systems (UMLS)
whose main objective is to assist in the developing of natural lan-
guage technology for biomedical texts. UMLS has three major knowl-
edge sources: the Metathesaurus, the Semantic Network and the
Specialist Lexicon. The MetaMap Transfer (MMTx) program [19] ana-
lyzes the texts syntactically and selects the concepts of the UMLS
Metathesaurus that best ﬁt a certain phrase.
DrugBank [3,20] is an annotated database with about 4900 drug
entries. Each entry contains more than 100 data ﬁelds that gather
detailed chemical and pharmacological information (type, cate-
gory, brand name, chemical formula, drug interactions, etc.).
Regarding the drug target information contained in DrugBank, each
drug is related to one or more drug targets. DrugBank’s list of drug
targets has been manually compiled from several drug targets
sources such as TTD or the list provided by [1]. DrugBank also con-
tains a set of MedLine article references for each drug target.
2.2. Text mining tools for biomedical information retrieval
Recently, Bioalma, a Spanish IT company specialized in the re-
search and development of biomedical software, has launched
NovoSeek6, a tool that may be serve as a search engine alternative
to PubMed. NovoSeek ranks the retrieved documents according to
biomedical concepts such as diseases, drugs, genes, among others.
In addition, this tool helps users to improve their queries by the
use of synonyms.
EBIMed [14] is a service developed by the European Bioinfor-
matics Institute (EBI) to retrieve information from MedLine. As it
was mentioned in the Introduction, this tool combines document
retrieval with co-occurrence-based analysis of MedLine abstracts.
EBIMed has been mainly focused on improving the access to infor-
mation about protein–protein interactions and effects of drugs on
proteins (drug targets).
iHOP (information Hyperlinked Over Proteins) [21] is a web ser-
vice that automatically extracts key sentences from MedLine doc-
uments. Genes, proteins and chemical compounds terms are
annotated and linked to MeSH terms by machine learning
methods.
2.3. Biomedical text classiﬁcation
In recent years, several competitions such as KDD 2002 Chal-
lenge Cup [22], TREC Genomics Track or BioCreAtIvE (Critical
Assessment for Information Extraction in Biology) Challenges have
promoted research on text classiﬁcation methods in the biomedi-
cal domain, since they provide a suitable framework and datasets
for evaluating and comparing different approaches.
KDD 2002 Cup focused on identifying what papers contain
experimental evidence for Drosophila gene expression. TREC
2004 and 2005 Genomics Tracks, [24,25], pursued the classiﬁcation
of full-text documents simulating the task of curators for the
Mouse Genome Informatics (MGI)7 database [23]. In both tracks,5 http://www.ncbi.nlm.nih.gov/pubmed/.
6 http://www.novoseek.com/Welcome.action.
7 http://www.informatics.jax.org/.
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chines (SVN) or Naïve Bayes were used by a variety of teams [26–
29]. Regarding the representation of documents, several techniques
such as porter stemmer algorithm, selection of n-grams, and stop-
words were used, achieving the best results in those approaches that
involved the use of MeSH terms. However, the best results only
achieved 0.66 of F-measure.
Closer to our goals, the extraction of protein–protein interac-
tions (PPI) from texts is one of three tracks proposed by BioCre-
AtIvE Challenges to tackle the problem of classiﬁcation of articles
from PubMed abstracts for database curation relevant to protein–
protein interactions. A detail description of the subtasks as well
as a comprehensive review of the participating systems can be
found in [30,31]. Most participants used machine learning tech-
niques such as SVM, Naïve Bayes or Maximum Entropy classiﬁers.
Regarding the representation of the documents, participating
teams mostly used the traditional bag-of-words approach with
small variations. Stemming, POS tagging, Biomedical Named Entity
Recognition or integration of knowledge from biological resources
were the most used strategies to build the feature vector. In the
BioCreative II Challenge, the training corpus consisted of 3536
PPI-relevant (positive) abstracts and 1959 non-relevant (negative)
abstracts. The system presented in [32] achieved the best perfor-
mance with a precision of 0.71, and a recall of 0.87. This approach
used an SVM classiﬁer and applied the abovementioned prepro-
cessing techniques for adequate document representation. In addi-
tion, more sophisticated methods such as abbreviation resolution
were also introduced. In the last challenge, BioCreative II.5, the cor-
pora for the evaluation consisted of 1190 full articles from FEBS
Letters.8 The best system [33] was a Naïve Bayes classiﬁer imple-
mented using citation features such as cited PMIDs (unique number
assigned to each PubMed citation) and citation authors. The classiﬁer
achieved an F-measure of 0.63, a precision of 0.57 and a recall of
0.70, lower than the best ones in the previous challenge. This decline
in performance may be due to the classiﬁcation of full articles, which
involves greater complexity than abstracts.
In the pharmaceutical domain, Duda et al. [34] used an SVM
classiﬁer to identify drug–drug interactions articles. The authors
manually built a corpus composed of 2000 MedLine abstracts
(1800 negatives and 200 positives). Two different document repre-
sentations were used: the former is based on the use of UMLS iden-
tiﬁer concepts generated by MMTx, and the latter is based on the
common bag-of-words model, but MeSH terms are also included.
The results showed that the second representation achieved better
performance (0.99 of AUC) than the approach based on CUIs (0.98
of AUC).
In short, most approaches for biomedical text classiﬁcation use
machine learning methods such as SVM or Naïve Bayes. Regarding
the document representation, the approaches range from the com-
mon (binary, TF or TF-IDF) bag-of-words model to the use of more
sophisticated Natural Language Processing (NLP) techniques such
as chunking or biomedical named entity recognition. Semantic
information from biomedical resources has also been tentatively
used [35]. While most approaches achieve a high recall, there is a
need for further improvement in precision (which does not exceed
71%). Classiﬁcation tasks are mainly linked to curate biological dat-
abases, simulating the task of curators for genomic databases (like
MGI or FlyBase [36]) or protein interaction databases (such as In-
tAct [37] or MINT [38]). However, few approaches have tackled
the classiﬁcation of documents related to the pharmaceutical re-
search domain.
In this paper, a comprehensive study of several machine learn-
ing algorithms is addressed in order to determine which algorithm8 http://www.febsletters.org/, split evenly into training and test set.is the most suited for drug target article identiﬁcation task. As this
is the ﬁrst work that addresses this issue, a corpus has been created
in order to fairly evaluate and compare the algorithms.3. Our proposal
The main goal of our proposal is to maintain a service that que-
ries PubMed in a methodical and automated manner. Each new
article in MedLine can be classiﬁed as drug target or not, and sent
to drug target databases, which can update their data adequately.
The development of this system needs to address two prob-
lems: the construction of a corpus for drug target article classiﬁca-
tion, which is not yet available, and the learning of patterns from
the corpus for classiﬁcation purposes. The description of the cor-
pus, its construction and the techniques explored for classiﬁcation
are described in the following subsections.3.1. Building the corpus
We have built a corpus of positive and negative drug target ab-
stracts from DrugBank and PubMed. The corpus was created with
abstracts published between 1995 and 2001. About 5% of all articles
in MedLine concern drug targets. Such distribution was measured
querying PubMed about abstracts with the UMLS synonyms of the
term ‘‘biological target”. In thisway, anarticlewasmarkedas related
to drug target if it contained (or was annotated in MedLine with) at
least one of these synonyms. A set of 4365 abstracts (1500 of them
referred to drug target) was collected. Positive examples were ran-
domly selected from the references in DrugBank which were recov-
ered with the help of the RobotMaker9 tool. Negative examples were
randomly selected amongMedLine abstracts which were not marked
as drug target articles. Both sets contain only abstracts in the time
range 1995–2001, and the distribution amongst drug target and no
drug target abstracts observed in MedLine for each year was
maintained.
In order to assess the quality of the negative examples set, a 5%
(143) sample was randomly selected and manually evaluated with
the help of a pharmacist. The evaluation showed that none of the
abstracts were related to drug targets, supporting the quality of
the corpus.3.2. Preprocessing the corpus
A general schema of the corpus preprocessing appears in Fig. 1.
The dotted squares are the ﬁnal recovered data. After the set of
randomly selected abstract examples has been recovered from
MedLine and DrugBank (as explained in the previous section), a
set of features are extracted in order to build a representation of
each article. We were able to obtain, querying PubMed, title, ab-
stract and MeSH and chemical concepts associated to each ab-
stract, because they are ﬁelds of MedLine database.
Chemical concepts were extracted using NameOfSubstance data
in chemical list ﬁeld at MedLine database, which belong to MeSH
vocabulary. Therefore, we deﬁne two features: chemical concepts
with the content of chemical list ﬁeld in MedLine, and MeSH feature
with the non-chemical concepts at MeSH ﬁeld. These two features
are used in the training set to express the appearance of the related
concept with the corresponding example.
From title and abstracts we recovered the semantic types and
groups, as well as the stemmed words and drug families associated
to each of these parts. Word stems have been extracted using the
Porter stemmer algorithm.9 http://openkapow.com/.
Fig. 1. Corpus preprocessing.
Fig. 2. Concept ‘Aspirin’ retrieved by MMTx.
10 http://www.who.int/medicines/services/inn/en/.
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MMTx [19] analyzes the text syntactically in order to split it
into components of different syntactic levels: sentences, phrases,
lexical elements and tokens. Then, MMTx generates variants from
each phrase to look up the concepts in the UMLS Metathesaurus
that contain one or more of these variants. In this way, a set of can-
didate concepts are retrieved from the UMLS Metathesaurus and
are evaluated against the phrases using a linguistically rigorous
metric. Those candidates that best ﬁt the text are selected and or-
ganized into a ﬁnal mapping. Furthermore, MMTx also retrieves
the semantic types assigned to each concept. Thus, each phrase
may be related to one or more UMLS concepts together with their
semantic types.
Fig. 2 shows what information is retrieved by MMTx for the
phrase ‘‘Aspirin may decrease the effects of probenecid, sulﬁnpyra-
zone, and phenylbutazone”. For this phrase the ﬁnal mapping of
MMTx consists of an unique concept, Aspirin, with identiﬁer
(CUI) C0004057 and semantic type Pharmacological substance.
Semantic types offer very useful information. However, it would
be helpful if the semantic annotation of titles or abstracts had less
granularity. There are 136 semantic types, grouped in 15 semantic
groups [39] in the UMLS Semantic Network. For example, ‘‘Anat-
omy” (ANAT) semantic group refers to concepts associated,
amongst others, to ‘‘Anatomical Structures” and ‘‘Tissue” semantic
types. Therefore, we used the links between semantic type and
groups in UMLS Semantic Network to recover the semantic groups
associated to titles and abstracts in our examples.3.2.2. DrugNer
Each abstract is preprocessed by the DrugNer [40] system for
drug name recognition and classiﬁcation. DrugNer extends the
information provided by MMTx, by the use of the nomenclature
rules recommended by the WHO International Nonproprietary
Names (INNs) Program10 to identify and classify pharmaceutical
substances. Once abstracts have been processed by MMTx and the
phrases occurring in the text are annotated and related to concepts
of the UMLS Metathesaurus and to semantic types of the UMLS
Semantic Network, a second rule-based module classiﬁes the phar-
macological substances (that is, those phrases that have been related
to the UMLS semantic types which represent generic drugs: ‘‘antb”
or ‘‘phsu”) occurring in texts into pharmacological families. This
module implements the naming convention rules deﬁned by the
WHOINNs Program to facilitate the identiﬁcation and classiﬁcation
of pharmaceutical substances or active ingredients. The rules are
based on the common afﬁxes selected and deﬁned by WHOINN.
These common afﬁxes aid healthcare professionals to recognize that
the substance belongs to a group of substances having similar phar-
macological activity or chemical structure.
Table 1 shows some of the afﬁxes used in the classiﬁcation of
drug names. The full list and the afﬁx classiﬁcation can be found
in [41].
Table 1
Some afﬁxes recommended by WHOINN.
Afﬁxes Drug family
-ﬂurane General anaesthetics, volatile
-arol, -grel-, -irudin, -pafant, -troban Anticoagulants
-oxetine Antidepressants
-aﬁl, -dil, -entan Vasodilators
Table 2
Examples of matching phrases and afﬁxes.
Drug Suitable afﬁxes Most suitable afﬁx
Azelnidipine -dipine, -pine, -ine, -ni- -dipine
Lopinavir -navir, -vir- -navir
Amiodarone -arone, -one, -io-, -arone
Minocycline -cycline, -ine -cycline
Aripiprazole -piprazole, -prazole -piprazole
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regular expression for each afﬁx. For example, for the aﬁx -adol-,
the regular expression should be [A-Za-z0-9]*adol[A-Za-z0-9]*.
Therefore, any alphanumeric string which contains the aﬁx -adol-
is recognized by this regular expression. Once the regular expres-
sions have been built, the module tries to match the text of each
phrase with the regular expressions in order to detect the possible
afﬁxes, which may classify the phrase. In the case in which several
regular expressions can be matched with the text of the phrase, the
module selects the longest afﬁx.
Table 2 shows some examples. When a correct afﬁx is found, the
pharmacological or chemical family associated with the afﬁx is
added to the phrase. The rules are not only applied to the phrases
that have been classiﬁed as pharmacological substances or as anti-
biotics by the MMTx program, but also to those for which MMTx
did not found any candidate concept in UMLS. Thus, these phrases
are possible new candidates for drug names that are not included
in UMLS Metathesaurus.
A more detailed description of the DrugNer system is described
in [40]. A corpus of 875 MedLine abstracts was automatically anno-
tated by DrugNer, and subsequently manually-evaluated by a
pharmacological expert. This corpus is available for research pur-
poses11, but unfortunately, it contains some syntactic and semantic
errors made by the MMTx program, but we have not addressed this
problem yet.
3.3. Document representation
All features previously described are used to construct the ﬁnal
dataset for drug target article classiﬁcation. The set of collected
features are summarized as follows:
1. Chemical terms (chem): UMLS terms about drugs and chemical
products used by the authors to characterize their article
(extracted from the ﬁeld MESH of PubMed database),
2. MeSH terms (MeSH): other UMLS terms, different from the
chemical terms, used by the authors to characterize their article
(extracted from the ﬁeld MESH of PubMed database),
3. The stemmed words of the title (stemTitle),
4. The stemmed words of the abstract (stemAbstract),
5. Drug afﬁxes (drug): the drug families mentioned in the abstract
(extracted by using DrugNer system),
6. Semantic types and groups (semTypeGroup): semantic types and
groups of the mentioned UMLS terms (extracted by using
MMTx and Semantic Network).11 http://basesdatos.uc3m.es/index.php?id=359.The ﬁrst two features are represented as boolean vectors,
describing whether chemical and MeSH terms appear in the
respective PubMed data of the article. Title and abstract features
are transformed using the classical string feature representations:
term frequency (TF), term frequency-inverse document frequency
(TF-IDF) and term frequency-inverse document frequency with
normalization (TF-IDF-Norm). We analyze the effect of using each
kind of representation in the classiﬁcation results. All other fea-
tures are integer data, describing the frequency with which a con-
cept appears in the respective article. The notation used in ﬁgures
and tables in the remainder of the paper is speciﬁed in the above
list in italic. Afﬁxes TF, TF-IDF and TF-IDF-Norm are used to clarify
which kind of string representation is used; Title and Abstract af-
ﬁxes are used to specify the context in which a determined feature
is extracted, and AllVars is the notation used when all features are
considered.
3.4. Machine learning techniques
A set of machine learning algorithms for binary drug target arti-
cle classiﬁcation have been tested: C4.5 [42]; Bayesian statistics as
Naïve Bayes [43], Complement Naïve Bayes [44] (CNB), Bayes Net-
work [45] and DMNBtext [46]; LogitBoost [47] and its combination
with trees, the Logistic Model Trees (LMT) [48,49]; Fuzzy Lattice
Reasoning (FLR) [50,51]; Support Vector Machine (SVM) [52], and
HyperPipes [53] (HP).
These algorithms cover different kinds of machine learning
techniques (decision trees, Bayesian statistics, feature space divi-
sion, etc.) and share characteristics that make them interesting to
our analysis: (a) they all have been used in text classiﬁcation tasks
with good results; (b) they have efﬁcient implementations; and (c)
the resulting model allows a fast classiﬁcation processing. All
experiments have been performed according to the classical sche-
ma for selecting optimal classiﬁcation parameters, i.e, ﬁrst, we
have selected attributes in order to eliminate dependent sets of
features and then, we have optimized the parameters for each clas-
siﬁer. We ﬁnally compare of the results and select the best param-
eter conﬁgurations.4. Experimental results
Several experiments were carried out in order to validate the
proposed classiﬁer for drug–target articles. Since the observed ra-
tio between the number of positive and negative examples is
highly unbalanced, we have studied the effect of using different
proportions in positive and negative examples in the training set.
Therefore, we have considered 4 training datasets containing 5%
(real distribution), 10%, 20% and 50% of positive examples respec-
tively, in which the different training sets share as many examples
as possible. This solution reduces the possibility of meaningless re-
sults due to differences in training data. In Fig. 3 the four training
datasets are represented with different colors, to show the propor-
tion and overlap between their positive and negative subsets.
All experiments were performed using the Weka package [53],
and a 10-fold cross-validation framework was employed for testing
the results. A parameter selection process was performed for each
training set. An exhaustive search was performed for those algo-
rithms with more than two parameters, a grid search for those
algorithms with two parameters, and the optimizing tools pro-
vided for libSVM package [54] were used in the case of the SVM
classiﬁer.
In order to evaluate the classiﬁcation results we have computed
the ROC area measure, because in the last years many authors have
recognized its importance in order to give a more realistic vision of
the quality of binary classiﬁcations [56]. This measure gives an idea
Fig. 3. Distribution of positive and negative examples in the four analyzed training sets.
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(1.0) between true and false positive rates. However, ROC area
measure offers an excessively optimistic assessment of the results
when there is a large skew in the class distribution [57]. For this
reason, we have also employed the classical metrics of precision
(P), recall (R) and Fb-measure, more suitable to tasks with a large
skew in the class distribution. Precision is associated with the
capacity of classifying instances correctly, while recall is associated
with the capacity of classifying as many instances as possible; the
Fb-measure offers a global description considering both precision
and recall. For Fb-measure we have used the parameter
b ¼ f1;2g: Fb ¼ ð1þ b2ÞPR=ðb2

P þ RÞ. With b ¼ 1, the classical
F1-measure is obtained; when b ¼ 2, an overall performance is ob-
tained which gives more importance to recall.Fig. 4. Minimum (left columns) and maximum (right colum4.1. Feature selection
The feature selection phase, also known as attribute selection,
variable selection or feature reduction is used in Machine Learning
for selecting a subset of relevant features in order to construct
robust models from datasets. For feature selection, Correlation Fea-
ture Subset Selection (CFS) algorithm [59], Symmetrical Uncertain
(SymUncert) [60], Information Gain (InfoGain) [60], Gain Ratio
(GainRatio) [60], Relief [65,66] and Chi Squared (ChiSquared) [67]
metrics have been used in this work.
Fig. 4 represents the minimum and maximum percentages of
dimensionality after reduction for each feature and training set
distribution. Very similar performances are obtained for the train-
ing sets with 20% or 50% of positive examples (Figs. 5(a) and (b)).ns) percentages of features selected per distribution.
Fig. 5. Minimum and maximum percentage of feature selected per algorithm.
Table 3
Classiﬁcation results using different string feature representation.
String repres. Feature Real (5%) 10% 20% 50%
F1
TF stemTitle 0.871 0.918 0.800 0.916
stemAbstract 0.893* 0.928 0.817 0.923
AllVars 0.641 0.736 0.832 0.917
TF-IDF stemTitle 0.875 0.918 0.779 0.920
stemAbstract 0.887 0.928 0.824 0.924
AllVars 0.866 0.938* 0.871 0.949*
TF-IDF-Norm stemTitle 0.669 0.662 0.801 0.890
stemAbstract 0.634 0.843 0.830 0.923
AllVars 0.634 0.854 0.880* 0.936
F2
TF stemTitle 0.865 0.893 0.866 0.947
stemAbstract 0.904* 0.925 0.878 0.950
AllVars 0.669 0.793 0.873 0.941
TF-IDF stemTitle 0.871 0.895 0.871 0.950
stemAbstract 0.902 0.925 0.891 0.957*
AllVars 0.897 0.953* 0.856 0.956
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semantic groups cannot be reduced very much, but this does not
affect the reduction when all features are used together (see the
last three columns of Figs. 4(a) and (b)).
Comparing the four histograms of Fig. 4, the general behavior of
dimensionality reduction for all features can be analyzed. Features
stemTitle and stemAbstract features obtain drastic reductions of at
least 82% (and up to over 99.9%). All semantics features (semantic
types and groups, MeSH and chemical terms as well as drugs) are
drastically reduced in the majority of the cases between 85% and
95%. These data conﬁrm that ontologies describing semantic types
and groups, UMLS concepts and pharmacological families deﬁne
orthogonical spaces of knowledge that can be useful for clustering
and classiﬁcation tasks.
However, the severe reduction of the drug family feature indi-
cates the high dependence among drug families (the reference to
one of them implies a subsequent reference to others). This may
explain why the use of such feature does not help in drug–target
article classiﬁcation, as we show in Section 4.3.
When all features are used together, selection reduction is be-
tween 72% and 96%, a range that can be explained considering
the orthogonality of the majority of features previously described,
and the reductions obtained in each case.
Fig. 5 shows the results obtained by each feature selection algo-
rithm in the process of feature dimensionality reduction. The Chi-
squared measure gets the highest reduction, but just for the corpus
associated to the real data distribution (in the other cases the
reduction is at most 50%). The utility of a feature selection measure
is linked its classiﬁcation accuracy. The above analysis on feature
reduction can be especially useful when the number of features
should be reduced for computational efﬁciency while running data
mining algorithms. In such cases, we recommend to test the per-
formances with Gain Ratio, CFS selections and/or ReliefF selections,
since the Symmetrical Uncertain and Information Gain show very
low reductions considering different features and distributions.TF-IDF-Norm stemTitle 0.754 0.776 0.824 0.927
stemAbstract 0.795 0.911 0.889 0.952
AllVars 0.743 0.924 0.897* 0.948
ROC
TF stemTitle 0.951 0.944 0.953 0.960
stemAbstract 0.969 0.961 0.971 0.976
AllVars 0.962 0.973 0.970 0.966
TF-IDF stemTitle 0.950 0.939 0.959 0.959
stemAbstract 0.970* 0.961 0.970 0.976
AllVars 0.955 0.977* 0.980* 0.988*
TF-IDF-Norm stemTitle 0.908 0.924 0.944 0.949
stemAbstract 0.967 0.964 0.966 0.970
AllVars 0.955 0.971 0.971 0.9754.2. Analyzing string feature representations
We have analyzed three different representations for string fea-
tures: term frequency (TF), term frequency-inverse document fre-
quency (TF-IDF) and term frequency-inverse document frequency
with normalization (TF-IDF-Norm). For this analysis we have cre-
ated 36 corpora from the original training data which are the com-
bination of: (a) each positive set distribution; (b) each of the three
speciﬁc string representations; and (c) each of the following set of
features: (c.1) all features, (c.2) just the stemTitle features or (c.3)
just the stemAbstract features. All these corpora have been used
to train the algorithms presented in Section 3.4.Table 3 shows the best classiﬁcation results for each combina-
tion of training data and Table 4 shows the classiﬁers that have
achieved such results. Each classiﬁer is described by its selection
feature and classiﬁcation algorithms. We veriﬁed by Mc Nemar
hypothesis test [63] that no other classiﬁers constructed with the
same positive example distribution are statistically equivalent to
the best ones appearing in the table.
All metrics achieve the best results using the same conﬁgura-
tion (feature and string representation type) for each distribution
(see values marked with a star in Table 3). For a 5% distribution
of positive examples, the ideal conﬁguration is stemAbstract with
TF representation; for 10% and 50% distributions, the best solution
is to use AllVars features with TF-IDF representation; for 20% distri-
bution, AllVars features with TF-IDF-Norm representation. The
exceptions to this pattern (F2 measure for 50% distribution and
ROC measure for 20%) improve only by a 0.01 their corresponding
‘‘ideal” conﬁgurations.
The corpus composed of the stemAbstract features shows better
performance than the corpus composed of the stemTitle features,
for all metrics, especially when normalization is performed (see
rows TF-IDF-Norm in Table 3). The reason for this difference could
be that the normalization of TF-IDF values with respect to docu-
ment length gives more importance to words belonging to short
abstracts (or titles). In this way, essential patterns for the classiﬁ-
cation task in large texts may be not detected. TF and TF-IDF repre-
sentations show similar results for both stemAbstract and stemTitle
features. For real and 10% distributions, TF representation obtains
much better F1 and F2 scores for these features than using AllVars
features. This result corresponds with previous works based only
on bag of words for the classiﬁcation task. For all distributions (ex-
cept 5%), all features with a TF-IDF (instead of TF) representation
improve by at least a 3% the results achieved by the stemTitle and
Table 4
Classiﬁers associated to classiﬁcation results in Table 3.
String repres. Feature Real (5%) 10% 20% 50%
F1
TF stemTitle ChiSquared;FLR* InfoGain;FLR* SymUncert;SVM SymUncert;CNB*
stemAbstract SymUncert;FLR* SymUncert;FLR* SymUncert;DMNBtext SymUncert;DMNBtext
AllVars CFS;SVM CFS;LogitBoost CFS;SVM CFS;BayesNet*
TF-IDF stemTitle InfoGain;FLR* GainRatio;FLR* GainRatio;SVM InfoGain;CNB*
stemAbstract InfoGain;FLR* GainRatio;FLR* GainRatio;DMNBtext InfoGain;CNB*
AllVars GainRatio;FLR* GainRatio;FLR* GainRatio;FLR* GainRatio;FLR*
TF-IDF-Norm stemTitle InfoGain;FLR* CFS;CNB* SymUncert;SVM InfoGain;CNB*
stemAbstract InfoGain;CNB* GainRatio;FLR* GainRatio;SVM InfoGain;DMNBtext*
AllVars GainRatio;SVM* GainRatio;FLR* GainRatio;SVM GainRatio;SVM*
F2
TF stemTitle ChiSquared;FLR InfoGain;FLR SymUncert;CNB SymUncert;CNB
stemAbstract SymUncert;FLR SymUncert;FLR SymUncert;CNB SymUncert;CNB
AllVars CFS;BayesNet CFS;BayesNet CFS;NaiveBayes CFS;BayesNet
TF-IDF stemTitle InfoGain;FLR GainRatio;FLR GainRatio;CNB InfoGain;CNB
stemAbstract InfoGain;FLR GainRatio;FLR GainRatio;CNB InfoGain;CNB
AllVars GainRatio;FLR GainRatio;FLR GainRatio;FLR GainRatio;FLR
TF-IDF-Norm stemTitle InfoGain;FLR CFS;CNB SymUncert;CNB InfoGain;CNB
stemAbstract InfoGain;CNB GainRatio;FLR GainRatio;CNB InfoGain;CNB
AllVars GainRatio;FLR GainRatio;FLR GainRatio;FLR GainRatio;SVM
ROC
TF stemTitle ChiSquared;NaiveBayes InfoGain;CNB SymUncert;DMNBtext SymUncert;DMNBtext
stemAbstract SymUncert;NaiveBayes SymUncert;BayesNet SymUncert;HP SymUncert;HP
AllVars CFS;NaiveBayes CFS;LogitBoost CFS;LogitBoost CFS;LogitBoost
TF-IDF stemTitle InfoGain;NaiveBayes GainRatio;NaiveBayes GainRatio;DMNBtext InfoGain;DMNBtext
stemAbstract InfoGain;NaiveBayes GainRatio;BayesNet GainRatio;HP InfoGain;HP
AllVars GainRatio;FLR GainRatio;FLR GainRatio;HP GainRatio;HP
TF-IDF-Norm stemTitle InfoGain;NaiveBayes ReliefF;LogitBoost SymUncert;LogitBoost InfoGain;DMNBtext
stemAbstract InfoGain;BayesNet GainRatio;FLR GainRatio;DMNBtext InfoGain;DMNBtext
AllVars GainRatio;BayesNet GainRatio;FLR GainRatio;DMNBtext GainRatio;HP
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values for all distributions and representations, obtaining the max-
imum values when TF-IDF representation is used. Taking into ac-
count these insights, we justify the preference to use the TF-IDF
representation for the string features, and the results showed in
the next sections are thus based on the use of the TF-IDF
representation.
With respect to the classiﬁers associated to each result (see Ta-
ble 4), the following issues can be drawn. In the majority of cases,
the best F1 and F2 values are achieved using the same combination
of algorithms. A prevalence of the combination InfoGain or GainRa-
tio with the FLR classiﬁer can be observed when there are few po-
sitive examples (5% or 10%), whilst GainRation with SVM or CNB
prevail for the other distributions. The best results in ROC area
are obtained with probabilistic approaches, such as BayesNet and
NaiveBayes (5% and 10% distributions), as well as with text-direc-
ted approaches such as HyperPipes and DMNBtext.
4.3. Feature analysis
We have studied the behavior of the features for the different
positive set distributions in the classiﬁcation task (see Table 5).
We have classiﬁed the features into ﬁve groups, according to the
type of information that they represent: (1) stemTitle and stemAb-
stract features, (2) MeSH and chemical terms, (3) semantic types
and groups in titles and abstracts, (4) drug afﬁxes in title and ab-
stracts and (5) all features.
The features of the ﬁrst group show a similar behavior, and the
use of abstracts is advantageous in most cases for all measures and
distributions, with up to a 5% improvement. This result is easily
justiﬁable by the relative increase of knowledge offered by the ab-
stract in relation to the article’s title only.A somewhat unexpected result is obtained for the second group
of features: MeSH terms are less informative than the chemical
terms for real and 10% distributions (up to 5% of difference). A con-
trary situation is observed for 20% and 50% distributions (up to 17%
of difference). In the case of ROC area, the MeSH terms are more
discriminative than chem ones, except for the real distribution.
The three features of the family semTypeGroup show very simi-
lar results between them, with a difference of less than 2% in most
of the cases. The classiﬁcation performance improves slightly when
semTypeGroup_TitleAbstract is used (except for F2 and ROC mea-
sures in the case of 20% of positive examples), but at the price of
the additional effort of analyzing and using the semantic informa-
tion contained in abstracts. In contrast to stems, semantic types
and groups of titles provide better classiﬁcation results than
semantic types and groups of abstracts.
The fourth group shows an unusual behavior compared to the
rest of the features. In fact, the drug families mentioned in title
and abstract of articles are not useful in the classiﬁcation process.
The only acceptable score is achieved for F2 measure when the
dataset with 50% of positive examples is used.
When all informative features are used, classiﬁcation results are
clearly better for all measures and positive class distribution equal
or over 10% (in Table 5 the highest values per measure and distri-
bution are marked with a star). Therefore, all above features give a
contribution to the overall results.
The algorithms associated to the above results are shown in
Table 6, in which we have omitted the rows associated to drug
families because these attributes are not useful for our classiﬁca-
tion task. We veriﬁed by Mc Nemar hypothesis test that no other
classiﬁers constructed with the same positive example distribution
are statistically equivalent to the best ones appearing in the table.
For stems (stemTitle and stemAbstract), MeSH and chem features,
Table 5
Classiﬁcation results by feature and distribution of positive examples.
Feature Real (5%) 10% 20% 50%
F1
stemTitle 0.875* 0.918 0.779 0.920
stemAbstract 0.887 0.928 0.824 0.924
MeSH 0.813 0.848 0.829 0.930
chem 0.856 0.886 0.716 0.859
semTypeGroup_Title 0.459 0.620 0.701 0.873
semTypeGroup_Abstract 0.422 0.563 0.697 0.873
semTypeGroup_TitleAbstract 0.492 0.635 0.740 0.887
drug_Title 0.000 0.013 0.201 0.673
drug_Abstract 0.105 0.081 0.207 0.664
AllVars 0.866 0.938* 0.871* 0.949*
F2
stemTitle 0.871 0.895 0.871 0.950
stemAbstract 0.902* 0.925 0.891* 0.957
MeSH 0.770 0.795 0.871 0.944
chem 0.823 0.843 0.704 0.849
semTypeGroup_Title 0.557 0.692 0.784 0.903
semTypeGroup_Abstract 0.510 0.663 0.769 0.902
semTypeGroup_TitleAbstract 0.561 0.700 0.712 0.904
drug_Title 0.000 0.008 0.200 0.836
drug_Abstract 0.071 0.053 0.208 0.827
AllVars 0.897 0.953* 0.856 0.956*
ROC
stemTitle 0.932 0.938 0.959 0.959
stemAbstract 0.953 0.958 0.970 0.976
MeSH 0.870 0.962 0.966 0.968
chem 0.900 0.907 0.817 0.867
semTypeGroup_Title 0.936 0.938 0.934 0.926
semTypeGroup_Abstract 0.936 0.923 0.926 0.918
semTypeGroup_TitleAbstract 0.943 0.942 0825 0.933
drug_Title 0.500 0.503 0.504 0.516
drug_Abstract 0.521 0.532 0.518 0.516
AllVars 0.955* 0.977* 0.980* 0.988*
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Gain or GainRatio feature selection algorithms with the FLR classi-
ﬁcation algorithm. For semantic type and groups features, it is not
clear what conﬁguration allows to obtain the best results. How-
ever, CFS with BayesNet as well as InfoGain with DMNBtext are
the most frequent combinations. When all features are used, the
FLR algorithm (or HyperPipes in the case of ROC area, for 20%
and 50% of positive examples), preceded by a Gain Ratio feature
selection, achieved the best results.
Comparing the results of using different distributions of posi-
tive and negative examples, we observe that a 20% of positive
examples does not guarantee to obtain higher results than with a
10% of positive examples. The use of all features shows increasing
F1, F2 scores as the distribution of positive examples is increased,
but with lower values for the 20% distribution. This observation ﬁts
with various unbalanced biomedical binary classiﬁcation tasks, in
which the distribution is adjusted to 10% independently from the
real distribution of the classes, like in [34].
A detailed analysis of the above results allows us to determine
the following orders, representing the relative importance of the
features for classiﬁcation:
 For the distributions of 5% and 10% of positive examples: (1)
stemAbstract features, (2) stemTitle features, (3) MeSH and
chemical terms, (4) semantic type and groups features, and
(5) drug families features. For the distributions of 20% and 50%: (1) MeSH terms, (2) stem-
Abstract features, (3) stemTitle features, (4) semantic types and
groups features, (5) chemical terms, and (6) drug families
features.
In addition, we have performed a detailed analysis of the results
to choose the most informative features for each of the classiﬁers.
Table 7 shows the most informative features of the trained classi-
ﬁer models. The features have been selected taking into account
the ROC area as well as the F1 and F2 scores. We can observe that
most algorithms beneﬁt from using all features to train their
models.
4.4. Best classiﬁer conﬁgurations
All conﬁgurations providing the best result for at least one mea-
sure (precision, recall, F1, F2 or ROC area) have been included in the
set of best classiﬁers, independently of the class distribution. Table
8 shows the best conﬁgurations and their scores. Each conﬁgura-
tion is speciﬁed by an identiﬁer (ﬁrst column) described by: (a)
the class instances distribution (real (R), 10, 20, 50); (b) the used
feature(s); (c) the measure for feature selection; and (d) the statis-
tical machine learning algorithm employed. For example, 50;Stem-
Abstract;InfoGain;FLR means that the 50% distribution of positive
examples was used, the set of features consists of the stemAbstract
features which are ﬁltered using the InfoGain measure, and the
classiﬁcation is performed using the FLR classiﬁer. Only 10% and
50% distributions are represented in the set of the best conﬁgura-
tions. The last two rows of Table 8 show the best scores for the real
and 20% distributions. When the positive class represents 5% or
20%, all measures are relatively low, except for the ROC area.
According to the F1 measure, which gives the same importance
to precision and recall, the best classiﬁer is 50;AllVars;GainRatio;FLR
obtaining high quality values for all measures, with a 0.95 of F1-
measure, 0.96 of F2-measure and 0.95 of ROC Area. Classiﬁer 10;All-
Vars;GainRatio;FLR achieves similar results, and both classiﬁers
share the same conﬁguration, except the distribution of positive
examples. We believe that the best classiﬁer is thus the ﬁrst in Ta-
ble 8, because it obtains results similar to those obtained by other
classiﬁers, but needs less positive examples to train its model. We
used Mc Nemar’s test to examine if the 10;AllVars;GainRatio;FLR
classiﬁer is signiﬁcantly better than the other classiﬁers. The null
hypothesis H0 is no preference towards the 10;AllVars;GainRatio;FLR
classiﬁer. The alternative hypothesis H1 is deﬁned as there is a pref-
erence towards the 10;AllVars;GainRatio;FLR classiﬁer. We use a 95%
conﬁdence level for verifying/falsifying the hypothesis. The test re-
sults (see Table 9) indicate that, (in the 95% of the cases) the 10;All-
Vars;GainRatio;FLR classiﬁer obtains results equal to the classiﬁer
50;AllVars;GainRatio;FLR (which have the same conﬁguration but
a different class example distribution), and is signiﬁcantly better
than the other classiﬁers.
The FLR classiﬁer divides the parameter space in lattices, in
which abstracts sharing a common subset of properties and having
some similarities are grouped. The classiﬁer works with fuzzy
intervals instead of fuzzy numbers. This allows to produce a re-
duced set of fuzzy rules which achieves a clear and simple knowl-
edge representation of the drug target abstracts. The FLR classiﬁer
has been used for addressing several classiﬁcation tasks such as
ambient air quality assessment [61] and ocean satellite image rec-
ognition [62]. Its effectiveness has been showed by the high preci-
sion and recall values obtained in comparison with other
classiﬁers, such as C4.5, in which the number of rules generated
is often excessive.
The HyperPipes classiﬁer considers the ranges observed in the
training data for each feature and class. Then, the classiﬁer uses
this information to select the class that contains the largest
Table 6
Algorithms associated to classiﬁcation results in Table 5.
Feature real (5%) 10% 20% 50%
F1
stemTitle InfoGain;FLR GainRatio;FLR GainRatio;SVM InfoGain;CNB
stemAbstract InfoGain;FLR GainRatio;FLR GainRatio;DMNBtext InfoGain;CNB
MeSH InfoGain;FLR SymUncert;FLR SymUncert;SVM SymUncert;SVM
chem InfoGain;FLR SymUncert;FLR SymUncert;CNB SymUncert;CNB
semTypeGroup_Title InfoGain;DMNBtext SymUncert;SVM CFS;BayesNet CFS;BayesNet
semTypeGroup_Abstract InfoGain;DMNBtext CFS;BayesNet CFS;SVM CFS;SVM
semTypeGroup_TitleAbstract InfoGain;DMNBtext SymUncert;DMNBtext FilteredSubsetEval;SVM CFS;SVM
AllVars GainRatio;FLR GainRatio;FLR GainRatio;FLR GainRatio;FLR
F2
stemTitle InfoGain;FLR GainRatio;FLR GainRatio;CNB InfoGain;CNB
stemAbstract InfoGain;FLR GainRatio;FLR GainRatio;CNB InfoGain;CNB
MeSH InfoGain;FLR SymUncert;FLR SymUncert;NaiveBayes SymUncert;FLR
chem InfoGain;FLR SymUncert;FLR SymUncert;CNB SymUncert;CNB
semTypeGroup_Title InfoGain;BayesNet SymUncert;BayesNet CFS;BayesNet CFS;BayesNet
semTypeGroup_Abstract CFS;NaiveBayes CFS;CNB CFS;CNB CFS;SVM
semTypeGroup_TitleAbstract CFS;BayesNet CFS;BayesNet FilteredSubsetEval;SVM CFS;SVM
AllVars GainRatio;FLR GainRatio;FLR GainRatio;FLR GainRatio;FLR
ROC
stemTitle InfoGain;FLR GainRatio;FLR GainRatio;DMNBtext InfoGain;DMNBtext
stemAbstract InfoGain;FLR GainRatio;FLR GainRatio;HP InfoGain;HP
MeSH InfoGain;FLR CFS;NaiveBayes SymUncert;LogitBoost SymUncert;DMNBtext
chem InfoGain;FLR SymUncert;FLR SymUncert;CNB SymUncert;DMNBtext
semTypeGroup_Title InfoGain;DMNBtext CFS;BayesNet CFS;BayesNet CFS;BayesNet
semTypeGroup_Abstract InfoGain;DMNBtext CFS;BayesNet CFS;BayesNet CFS;DMNBtext
semTypeGroup_TitleAbstract InfoGain;DMNBtext SymUncert;DMNBtext FilteredSubsetEval;SVM CFS;DMNBtext
AllVars GainRatio;FLR GainRatio;FLR GainRatio;HP GainRatio;HP
Table 7
Most informative features for each classiﬁer.
Classiﬁer Metrics
F1 F2 ROC
BayesNet AllVars
CNB stemTitle (5%) stemTitle (5%);
stemAbstract (10,
50%);
stemAbstract
MeSH (20%) (10, 20, 50%)
DMNBtext AllVars (5, 20, 50%); AllVars (5, 50%); AllVars (5,
50%);
semTypeGroup (10%); stemAbstract
(10, 20%);
stemAbstract
(10, 20%);
stemAbstract (20%) MeSH (50%)
AllVars (5, 50%);
FLR stemAbstract (5%);
semTypeGroup (10%);
AllVars (20, 50%)
HP AllVars (5, 20%); AllVars (5, 20, 50%);
semTypeGroup (10%) semTypeGroup
(10%);
stemAbstract (50%)
C4.5 AllVars (5%); AllVars (5%);
semTypeGroup (10%); semTypeGroup
(10%);
MeSH (20%); MeSH (20, 50%)
stemAbstract (50%)
LMT MeSH (5, 20, 50%);
semTypeGroup (10%)
NaïveBayes MeSH (5, 20%);
semTypeGroup (10%);
stemAbstract (50%)
LogitBoost stemAbstract (5, 50%); stemAbstract (5%);
AllVars (10, 20%) AllVars (10, 20, 50%)
SVM AllVars
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reported good results especially when a large number of features is
considered, as in our case. Finally, the CNB classiﬁer shows the
lower scores amongst the best classiﬁers in Table 8, which may
be due the assumption that features are independent, unrealistic
in this domain.
It is difﬁcult to compare our work to other approaches, because
we are the ﬁrst to address the problem of classiﬁcation of drug tar-
get articles, and our experiments have been performed on a spe-
ciﬁc corpus for our task. Thus, our results are only partially
comparable to other works. As mentioned in section 2.3, the corpus
used in the BioCreative II Challenge has a higher proportion of po-
sitive abstracts (64.3%) than our corpus. However, the best perfor-
mance in the challenge was only 0.78 for F-measure. Our results
also improve those reported in the BioCreative II.5 Challenge
(where the best F-measure was 0.63 [33]), although the classiﬁca-
tion task there was substantially more difﬁcult, being applied to
full articles. Many works on classiﬁcation of protein interaction ab-
stracts have used the SVM classiﬁer, although they have not per-
formed a comparative analysis among different classiﬁers to the
depth and extent reported here. As reference, Table 10 shows the
best results for the different positive example distributions when
SVM is used. Increasing the number of positive examples allows
to improve all measures.5. Conclusions and future work
To the best of our knowledge, this is the ﬁrst work considering
the classiﬁcation task for drug–target articles to aid drug–target
database curation. In addition, our study provides a dataset which
can serve as a benchmark for encouraging the development of new
approaches.
Table 8
Best conﬁgurations for all distributions.
Id P R F1 F2 ROC
10;AllVars;GainRatio;FLR 0.915 0.963 0.938 0.953 0.977
50;AllVars;GainRatio;HP 0.966 0.917 0.941 0.926 0.988
50;AllVars;GainRatio;FLR 0.936 0.961 0.949 0.956 0.948
50;stemAbstract;InfoGain;CNB 0.875 0.980 0.924 0.957 0.920
R;stemAbstract;InfoGain;FLR 0.862 0.912 0.887 0.902 0.953
20;AllVars;GainRatio;HP 0.934 0.802 0.863 0.825 0.980
Table 9
Mc Nemar’test results for the better conﬁgurations, comparing with
10;AllVars;
GainRatio;FLR.
Id v Mc Nemar statistic p-value
50;AllVars;GainRatio;HP 47.457 0.00
50;AllVars;GainRatio;FLR 0.533 0.47
50;stemAbstract;InfoGain;CNB 99.849 0.00
R;stemAbstract;InfoGain;FLR 18.317 0.00
20;AllVars;GainRatio;HP 30.533 0.00
Table 10
Best results for SVM conﬁgurations.
Id P R F1 F2 ROC
R;stemTitle;InfoGain;SVM 0.867 0.526 0.655 0.570 0.761
10;AllVars;GainRatio;SVM 0.861 0.600 0.707 0.639 0.795
20;AllVars;GainRatio;SVM 0.866 0.850 0.858 0.853 0.909
50;AllVars;GainRatio;SVM 0.922 0.952 0.937 0.946 0.936
912 R. Danger et al. / Journal of Biomedical Informatics 43 (2010) 902–913Instead of the common bag-of-words approach, a novel repre-
sentation is proposed based on the use of semantic information
from biomedical resources such as UMLS, nomenclature rules for
naming drugs or MeSH vocabulary. Our main hypothesis is that
semantic information is useful to deal with the problem of data
sparseness.
We have performed an extensive experimental analysis using a
combination of techniques for feature selection and the most
important machine learning algorithms for text classiﬁcation
[64]. We have studied the behavior of features in relation with
attribute dimensionality reduction when feature selection algo-
rithms are applied, and with their contribution to the ﬁnal classiﬁ-
cation results. The best result has been achieved by a Fuzzy Lattice
Reasoning classiﬁer, reaching 0.94, 0.95 and 0.98 of F1, F2 and ROC
area, respectively. We plan to further improve the accuracy of our
classiﬁcation system taking into account the ﬁndings of the present
work. Furthermore, since many of the articles are also available in
full-text, we will include full article analysis in our future research.
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